Discover why the University of Oxford and Harvard lead the world in medicine for 2026. Explore Oxford’s #1 MBBS ranking, its unique tutorial system, and the various medical courses offered at this ...

In today’s In the Spotlight feature, we highlight the journey of Yuvraj Mehta, Founder and CEO of StrateRise Consulting, as a ...

This strategic affiliation increases access to world-class, academic-based gastroenterology and hepatology care throughout the region with the addition of ...

Professional hockey players who took education seriously often become the smartest guys in the locker room. Some completed ...

Grand Canyon Education (LOPE) remains a 'Buy' with 15–20% upside and buyback-driven total return potential near 25%.

We speak to Vincenzo Vinzi, Dean & President, ESSEC Business School about AI and its role in modern business leadership.

Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally ...

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need ...

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...

Examining the primary cost drivers that reshaped the industry in 2025 and their implications for financial planning in 2026.

The article discusses the evolving role of hospitalists and their unique skills that enable them to transition from clinical care to administrative leadership.